2022. The impact of tralokinumab on quality of life and school in patients aged 12–17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s77. DOI:https://doi.org/10.25251/skin.6.supp.77.